Several other regulations and policies apply to this part. These include, but are not necessarily limited to: 42 CFR part 50, Subpart A--Responsibilities of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science42 CFR part 50, Subpart D--Public Health Service grant appeals procedures42 CFR part 50, subpart F--Responsibility of applicants for promoting objectivity in research for which PHS funding is sought45 CFR part 16--Procedures of the Departmental Grant Appeals Board45 CFR part 46--Protection of human subjects45 CFR part 74--Uniform administrative requirements for awards and subawards to institutions of higher education, hospitals, other nonprofit organizations, and commercial organizations; and certain grants and agreements with states, local governments and Indian tribal governments45 CFR part 75--Informal grant appeals procedures 45 CFR part 76--Governmentwide debarment and suspension (nonprocurement) and governmentwide requirements for drug-free workplace (grants)45 CFR part 80--Nondiscrimination under programs receiving Federal assistance through the Department of Health and Human Services--Effectuation of Title VI of the Civil Rights Act of 196445 CFR part 81--Practice and procedure for hearings under part 80 of this title45 CFR part 84--Nondiscrimination on the basis of handicap in programs and activities receiving or benefiting from Federal financial assistance45 CFR part 86--Nondiscrimination on the basis of sex in education programs and activities receiving or benefiting from Federal financial assistance45 CFR part 91--Nondiscrimination on the basis of age in HHS programs or activities receiving Federal financial assistance45 CFR part 92--Uniform administrative requirements for grants and cooperative agreements to State and local governments45 CFR part 93--New restrictions on lobbying59 FR 14508 (March 28, 1994)--NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.
Note: This policy is subject to change, and interested persons should contact the Office of Research on Women's Health, NIH, Room 201, MSC 0161, BETHESDA, MD 20892-0601 (301-402-1770; not a toll-free number) to obtain references to the current version and any amendments. 59 FR 34496 (July 5, 1994)--NIH Guidelines for Research Involving Recombinant DNA Molecules.
Note: This policy is subject to change, and interested persons should contact the Office of Recombinant DNA Activities, NIH, Suite 323, 6000 Executive Boulevard, MSA 7010, BETHESDA, MD 20892-7010 (301-496-9838; not a toll-free number) to obtain references to the current version and any amendments. Public Health Service Policy on Humane Care and Use of Laboratory Animals, Office of Laboratory Animal Welfare, Office of Extramural Research, NIH (Revised September 1986).
Note: This policy is subject to change, and interested persons should contact the Office of Laboratory Animal Welfare, Office of Extramural Research, NIH, Rockledge 1, 6705 Rockledge Drive, Bethesda, Maryland 20817, telephone 301-594-2382 (not a toll-free number) to obtain references to the current version and any amendments. [57 FR 61006, Dec. 23, 1992, as amended at 61 FR 55109, Oct. 24, 1996; 68 FR 69622, Dec. 15, 2003]